Amlodipine And Olmesartan Medoxomil Tablet, Film Coated
Product Images NDC 42291-001

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Amlodipine And Olmesartan Medoxomil (NDC 42291-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (001 30)

1 (001 30)
The label is for Amlodipine and Olmesartan Medoxomil Tablets, USP, with each tablet containing 5 mg amlodipine and 20 mg olmesartan medoxomil, in a film-coated tablet dosage form. The package contains 30 tablets and is marked Rx Only. The label includes storage instructions, a barcode, and the labeler AvKARE's identification information.*
FDA Label Image

2 (002 30)

2 (002 30)
Label for Amlodipine and Olmesartan Medoxomil tablets, USP by AvKARE. The film-coated tablets have a strength of 5 mg amlodipine and 40 mg olmesartan medoxomil. The package contains 30 tablets for oral use and is marked Rx only. Additional storage and dosing instructions are included along with a QR code and barcode.*
FDA Label Image

3 (003 30)

3 (003 30)
A label for Amlodipine and Olmesartan Medoxomil Tablets, USP, 10 mg/20 mg, film-coated oral tablets. The label shows the brand AvKARE, NDC 42291-003-30, and indicates the package contains 30 tablets. The label includes dosage information, storage instructions to store at 25°C (77°F), and a QR code, along with manufacturer details.*
FDA Label Image

4 (004 30)

4 (004 30)
Packaging label for Amlodipine and Olmesartan Medoxomil Tablets, USP by AvKARE. The label shows the strength 10 mg/40 mg and indicates a package of 30 film-coated tablets for oral use with prescription only. The label includes the NDC 42291-004-30 and dosing information per tablet for amlodipine and olmesartan medoxomil.*
FDA Label Image

Figures 1 & 2 (Amlodipine And Olmesartan Medoxomil Tablets 1)

Figures 1 & 2 (Amlodipine And Olmesartan Medoxomil Tablets 1)
A line graph comparing the percentage of patients achieving systolic blood pressure below 140 mmHg across different baseline systolic blood pressure values for placebo, amlodipine 10 mg, olmesartan medoxomil 40 mg, and amlodipine and olmesartan medoxomil 10/40 mg tablets.*
FDA Label Image

Figures 1 & 2 (Amlodipine And Olmesartan Medoxomil Tablets 2)

Figures 1 & 2 (Amlodipine And Olmesartan Medoxomil Tablets 2)
A line graph depicting the percentage of patients with diastolic blood pressure (DBP) less than 90 mmHg plotted against baseline DBP values ranging from 95 to 110 mmHg. The graph compares four treatments: Placebo, Amlodipine 10 mg, Olmesartan Medoxomil 40 mg, and Amlodipine and Olmesartan Medoxomil tablets 10 mg/40 mg, indicated by distinct symbols and lines for each group.*
FDA Label Image

Figures 3 & 4 (Amlodipine And Olmesartan Medoxomil Tablets 3)

Figures 3 & 4 (Amlodipine And Olmesartan Medoxomil Tablets 3)
A line graph showing the percentage of subjects with systolic blood pressure (SBP) under 130 mmHg as a function of baseline SBP in mmHg. It compares four groups: placebo, OM 40 mg, AML 10 mg, and amlodipine and olmesartan medoxomil tablets 10/40 mg, with data points connected for each treatment group.*
FDA Label Image

Figures 3 & 4 (Amlodipine And Olmesartan Medoxomil Tablets 4)

Figures 3 & 4 (Amlodipine And Olmesartan Medoxomil Tablets 4)
A line graph depicting the percentage of subjects with diastolic blood pressure (DBP) below 80 mmHg versus baseline DBP (mmHg). Four treatments are compared: Placebo, Amlodipine 10 mg, Olmesartan Medoxomil 40 mg, and Amlodipine and Olmesartan Medoxomil tablets 10/40 mg, showing the combined tablets yielding the highest percentage achieving target DBP across baseline values.*
FDA Label Image

Amlodipine Chemical Structure (Amlodipine And Olmesartan Medoxomil Tablets 5)

Amlodipine Chemical Structure (Amlodipine And Olmesartan Medoxomil Tablets 5)
Chemical structure diagram showing the molecular composition of Amlodipine and Olmesartan Medoxomil, active ingredients in the combination drug product. The image depicts the detailed arrangement of atoms and chemical bonds of both components.*
FDA Label Image

Olmesartan Chemical Structure (Amlodipine And Olmesartan Medoxomil Tablets 6)

Olmesartan Chemical Structure (Amlodipine And Olmesartan Medoxomil Tablets 6)
Chemical structure diagram of Amlodipine and Olmesartan Medoxomil showing the molecular arrangement of atoms and bonds of the active ingredients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.